Answers are grounded in this paper and cite their sources.
Objective The objective was to compare paired pancreatic lipase immunoreactivity (PLI) concentrations and pancreatic lipase activity in serum samples in a population of azotemic dogs. Methods This observational study included client-owned dogs with azotemia and serum lipase activity above the reference interval (17 to 156 U/L). Lipase activity (Roche LIPC lipase colorimetric assay, substrate 1,2-o-dilauryl-rac-glycero-3-glutaric acid-[60-methylresorufin] ester) and serum creatinine concentration were measured as part of routine clinical diagnostics. Monthly screening identified leftover serum samples from azotemic dogs with hyperlipasemia. The PLI concentration was measured from banked serum aliquots of those samples. Associations between serum creatinine concentration, lipase activity, and PLI concentration were evaluated using correlation analysis and generalized linear mixed-effects models. Results 49 serum samples from 32 dogs were included. Serum creatinine concentration weakly correlated with lipase activity (Spearman rank correlation coefficient = 0.36) and PLI concentration (Spearman rank correlation coefficient = 0.30). Generalized linear mixed-effects modeling identified a significant association between azotemia and lipase activity, whereas no significant association was identified for PLI concentration. Per 0.3-mg/dL increase in serum creatinine concentration, lipase activity increased by 1.11 U/L. Conclusions Although azotemia was statistically associated with a significant increase in lipase activity in azotemic dogs, the magnitude of this effect was negligible. Clinical Relevance Azotemia has no clinically relevant effect on the diagnostic interpretation of increased lipase activity in dogs.
No takes yet. Share an insight, caveat, or question.
Niemann et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: